Clinical Trial Update: Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the combination of topotecan and etoposide in patients with recurrent ovarian, fallopian tube, or primary peritoneal cancer; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Etoposide (Etoposide)
• Topotecan (topotecan)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Fallopian Tube Cancer, Ovarian Cancer | Phase 1 | Status: COMPLETED